Invention Grant
- Patent Title: Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
-
Application No.: US149099Application Date: 1993-11-03
-
Publication No.: US5736137APublication Date: 1998-04-07
- Inventor: Darrell R. Anderson , Nabil Hanna , John E. Leonard , Roland A. Newman , Mitchell E. Reff , William H. Rastetter
- Applicant: Darrell R. Anderson , Nabil Hanna , John E. Leonard , Roland A. Newman , Mitchell E. Reff , William H. Rastetter
- Applicant Address: CA San Diego
- Assignee: Idec Pharmaceuticals Corporation
- Current Assignee: Idec Pharmaceuticals Corporation
- Current Assignee Address: CA San Diego
- Main IPC: C12N15/02
- IPC: C12N15/02 ; A61K31/375 ; A61K31/573 ; A61K31/664 ; A61K31/704 ; A61K38/00 ; A61K39/395 ; A61K45/00 ; A61K47/48 ; A61K51/00 ; A61K51/10 ; A61P35/00 ; C07K16/28 ; C07K16/46 ; C12N1/21 ; C12N5/10 ; C12N15/09 ; C12P21/02 ; C12P21/08 ; C12R1/91 ; G01N33/53 ; C07K16/30 ; C12N5/20
Abstract:
Disclosed herein are therapeutic treatment protocols designed for the treatment of B cell lymphoma. These protocols are based upon therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies.
Public/Granted literature
- USD323079S Stackable chair Public/Granted day:1992-01-14
Information query
IPC分类:
